BioSpace News Archive

Drug Development

Gilead Announces Data from New Preclinical Study Evaluating a Combination of an Investigational TLR7 Agonist and an Investigational HIV Envelope Targeting Antibody in SHIV-Infected, Virally Suppressed Monkeys

Gilead Sciences, Inc. announced results from a preclinical study conducted in collaboration with researchers at Beth Israel Deaconess Medical Center evaluating the combination of a proprietary investigational oral toll-like receptor 7 (TLR7) agonist, GS-9620, and a proprietary investigational broadly neutralizing antibody (bNAb), PGT121, as part of an HIV eradication strategy.

March 4, 2018
·
3 min read
Drug Development

Aimmune Therapeutics Presents Results From the Positive, Pivotal Phase 3 PALISADE Trial of AR101 for Peanut Allergy at AAAAI-WAO

immune Therapeutics, Inc. announced that the results of its pivotal Phase 3 PALISADE trial of AR101 for the treatment of peanut allergy were presented today at the 2018 American Academy of Allergy, Asthma & Immunology–World Allergy Organization Joint Congress in Orlando.

March 4, 2018
·
4 min read
BioCapital

CareJourney President to Deliver Opening Keynote at HIMSS Innovation Symposium

CareJourney announced its President and Co-Founder, Aneesh Chopra, will deliver the opening keynote at the upcoming Healthcare Information and Management System Society (HIMSS) Innovation Symposium in Las Vegas, NV.

March 4, 2018
·
1 min read
Business

AURAK Enters MOU with Al Nuaimi Group

The American University of Ras Al Khaimah entered into a Memorandum of Understanding with Al Nuaimi Group LLC to augment research, help students prepare for competition, and improve job opportunities for students.

March 4, 2018
·
2 min read